- Vosaroxin plus cytarabine versus placebo plus cytarabine in patients with first relapsed or refractory acute myeloid leukaemia (VALOR): A randomised, controlled, double-blind, multinational, phase 3 study. The Lancet Oncology. 2015 Academic Article GET IT
Myelodysplastic syndromes are induced by histone methylation–altering ASXL1 mutations.
The Journal of clinical investigation.
Times cited: 42